Stay updated with breaking news from 31446210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veru (NASDAQ:VERU – Get Free Report) and U.S. Stem Cell (OTCMKTS:USRM – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Analyst Ratings This is a breakdown of […]
Veru (NASDAQ:VERU – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 10th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Veru (NASDAQ:VERU – Get Free Report) last issued its quarterly earnings data on Thursday, May 11th. The company reported ($0.44) earnings […]
Jefferies Financial Group upgraded shares of Veru (NASDAQ:VERU – Get Rating) from an underperform rating to a hold rating in a report published on Wednesday morning, MarketBeat Ratings reports. VERU has been the topic of several other research reports. Oppenheimer reduced their target price on shares of Veru from $14.00 to $9.00 and set an […]
Veru (NASDAQ:VERU – Get Rating) will be announcing its earnings results before the market opens on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. Veru (NASDAQ:VERU – Get […]
Veru Inc. (NASDAQ:VERU – Get Rating) – Analysts at HC Wainwright decreased their Q2 2023 EPS estimates for shares of Veru in a report issued on Wednesday, April 26th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings of ($0.31) per share for the quarter, down from their previous forecast of […]